FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2285913192> ?p ?o ?g. }

• W2285913192 endingPage "70" @default.
• W2285913192 startingPage "359" @default.
• W2285913192 abstract "Dose-effect regression lines for phenobarbital sodium (5-ethyl-5-phenyl barbiturate sodium), diphenylhydantoin sodium (5 ,5-diphenythydantoinate sodium, Dilantin) and seven combinations of these two drugs were determined in rats by the maximal electroshock seizure (M. E. S.) test and minimal neurotoxicity test. The quantity of drug used in each combination was selected from a graph constructed from the regression lines for phenobarbital and Dilantin and in such a manner that the sum of the individual components of effectiveness would equal the 50 per cent level of response. The composition of the seven combinations varied from 3 per cent phenobarbital and 97 per cent Dilantin to 80 per cent phenobarbital and 20 per cent Dilantin. The dose of each drug or drug combination producing the desired endpoint (protection or neurotoxicity) in 50 per cent of animals (ED 50 or TD 50 ) was observed and protective indices (P.I. = TD 50 /ED 50 ) were calculated. The results were statistically analyzed for type of joint action. The combinations were also tested for duration of anticonvulsant action. In addition, experiments were performed to determine the most suitable temporal sequence for giving the components of the drug mixtures and the optimal time at which the combinations should be tested. The conclusions reached may be summarized as follows: 1. The graphic method described for selecting combinations of two active drugs on the basis of components of effectiveness has general applicability to other pharmacological classes of drugs which have similar action and which yield parallel dose-response lines. It may also be used to evaluate the effects of combining more than two drugs with similar action. 2. It was shown that the graphically estimated ED 50 for a drug combination is reasonably close to the calculated ED 50 . This makes the graphically estimated ED 50 a valuable basis of reference when large numbers of drug combinations require screening. 3. Data were presented which indicate that a period of coaction of the individual components of a mixture is essential for maximal anticonvulsant activity. 4. Combinations III (phenobarbital 37.5 per cent and Dilantin 62.5 per cent), VI (phenobarbital 67.5 per cent and Dilantin 32.5 per cent), and VII (phenobarbital 80 per cent and Dilantin 20 per cent) were 1.25, 1.72 and 1.35 times, respectively, more potent than calculated on the basis of similar joint action of the component parts of the mixture. The remaining four combinations exhibited no significant alteration in anticonvulsant potency from that predicted. 5. The duration of anticonvulsant action for combinations II (phenobarbital 7.3 per cent and Dilantin 92.7 per cent) and VI was not significantly different from that of the major component. 6. Minimal neurotoxicities of combinations I (phenobarbital 3 per cent and Dilantin 97 per cent) and II were decreased 26 and 23 per cent, respectively, below that calculated on the basis of similar joint toxicity of their component parts, whereas the neurotoxicity of combination V (phenobarbital 62.5 per cent and Dilantin 37.5 per cent) was increased 23 per cent. There was no significant deviation in the toxicity of any of the remaining combinations from that predicted 7. The results obtained were not compatible with the prediction that mixtures of phenobarbital and Dilantin exhibit either similar joint action or independent joint action. However, until additivity on the basis of all possible types of joint action has been similarly excluded, and because of the difficulty of defining such terms, the observed alterations in intensity of individual effects cannot be interpreted with certainty as representing either potentiation or antagonism of anticonvulsant activity. 8. The P. I.9s for combinations VI and VII were 8.80 and 6.72, respectively; the former value represents a significant increase in the margin of safety over that of the most effective component in the mixture. There was no significant alteration in the P. I.9s of the remaining 5 combinations. The method employed herein for evaluating combinations of anticonvulsant drugs appears to offer a rational approach to the complex problem of combined drug action. The results presented indicate that increased anticonvulsant activity and enlarged margins of safety may be obtained with critical ratios of anticonvulsant drugs, and warrant a systematic evaluation of other anticonvulsant drug combinations." @default.
• W2285913192 created "2016-06-24" @default.
• W2285913192 creator A5005336199 @default.
• W2285913192 creator A5024167731 @default.
• W2285913192 creator A5040860845 @default.
• W2285913192 creator A5057357823 @default.
• W2285913192 date "1955-03-01" @default.
• W2285913192 modified "2023-09-23" @default.
• W2285913192 title "Studies on anticonvulsant drug combinations: phenobarbital and diphenylhydantoin." @default.
• W2285913192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14368504" @default.
• W2285913192 hasPublicationYear "1955" @default.
• W2285913192 type Work @default.
• W2285913192 sameAs 2285913192 @default.
• W2285913192 citedByCount "8" @default.
• W2285913192 countsByYear W22859131922014 @default.
• W2285913192 countsByYear W22859131922015 @default.
• W2285913192 countsByYear W22859131922021 @default.
• W2285913192 crossrefType "journal-article" @default.
• W2285913192 hasAuthorship W2285913192A5005336199 @default.
• W2285913192 hasAuthorship W2285913192A5024167731 @default.
• W2285913192 hasAuthorship W2285913192A5040860845 @default.
• W2285913192 hasAuthorship W2285913192A5057357823 @default.
• W2285913192 hasConcept C118552586 @default.
• W2285913192 hasConcept C178790620 @default.
• W2285913192 hasConcept C185592680 @default.
• W2285913192 hasConcept C2775858608 @default.
• W2285913192 hasConcept C2778186239 @default.
• W2285913192 hasConcept C2778337148 @default.
• W2285913192 hasConcept C2778793413 @default.
• W2285913192 hasConcept C2779491297 @default.
• W2285913192 hasConcept C2780035454 @default.
• W2285913192 hasConcept C2780077838 @default.
• W2285913192 hasConcept C29730261 @default.
• W2285913192 hasConcept C71924100 @default.
• W2285913192 hasConcept C98274493 @default.
• W2285913192 hasConceptScore W2285913192C118552586 @default.
• W2285913192 hasConceptScore W2285913192C178790620 @default.
• W2285913192 hasConceptScore W2285913192C185592680 @default.
• W2285913192 hasConceptScore W2285913192C2775858608 @default.
• W2285913192 hasConceptScore W2285913192C2778186239 @default.
• W2285913192 hasConceptScore W2285913192C2778337148 @default.
• W2285913192 hasConceptScore W2285913192C2778793413 @default.
• W2285913192 hasConceptScore W2285913192C2779491297 @default.
• W2285913192 hasConceptScore W2285913192C2780035454 @default.
• W2285913192 hasConceptScore W2285913192C2780077838 @default.
• W2285913192 hasConceptScore W2285913192C29730261 @default.
• W2285913192 hasConceptScore W2285913192C71924100 @default.
• W2285913192 hasConceptScore W2285913192C98274493 @default.
• W2285913192 hasIssue "3" @default.
• W2285913192 hasLocation W22859131921 @default.
• W2285913192 hasOpenAccess W2285913192 @default.
• W2285913192 hasPrimaryLocation W22859131921 @default.
• W2285913192 hasRelatedWork W1633937204 @default.
• W2285913192 hasRelatedWork W1876644323 @default.
• W2285913192 hasRelatedWork W1985469590 @default.
• W2285913192 hasRelatedWork W2031325622 @default.
• W2285913192 hasRelatedWork W2076728822 @default.
• W2285913192 hasRelatedWork W2091568588 @default.
• W2285913192 hasRelatedWork W2285913192 @default.
• W2285913192 hasRelatedWork W2357957538 @default.
• W2285913192 hasRelatedWork W2410567127 @default.
• W2285913192 hasRelatedWork W3098373555 @default.
• W2285913192 hasVolume "113" @default.
• W2285913192 isParatext "false" @default.
• W2285913192 isRetracted "false" @default.
• W2285913192 magId "2285913192" @default.
• W2285913192 workType "article" @default.